Spruce Biosciences, Inc.
SPRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001683553
No open-market purchases or sales by Spruce Biosciences, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $116.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Spruce Biosciences, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 31 | 31 | 0 |
| Shares | 11.2M | 10.5M | −728.1K (−6.5%) |
| Value | $4.69M | $3.03M | −$1.66M (−35.4%) |
New holders (5)
Institutions that held Spruce Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 47,686 | $13.8K | 0.00% |
| Virtu Financial LLC | 39,426 | $11.0K | 0.00% |
| Jane Street Group, LLC | 37,429 | $10.9K | 0.00% |
| Ground Swell Capital, LLC | 17,312 | $5.02K | 0.01% |
| Citigroup Inc | 11,083 | $3.21K | 0.00% |
Sold out (5)
Institutions that held Spruce Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sands Capital Ventures, LLC | 715,817 | $300.6K |
| Susquehanna International Group, LLP | 58,984 | $24.8K |
| HRT Financial LP | 37,838 | $15.0K |
| Bridgeway Capital Management, LLC | 34,900 | $14.7K |
| Simplex Trading, LLC | 4,857 | $2.00K |